
The clinical and molecular significance associated with STING …
2021年6月25日 · STING signaling in cancer is a crucial component of response to immunotherapy and other anti-cancer treatments. Currently, there is no robust method of measuring STING activation in cancer....
STING (D2P2F) Rabbit mAb | Cell Signaling Technology
Monoclonal Antibody for studying STING. Validated for IHC, IHC, IP, WB. Available in 2 sizes. Highly specific and rigorously validated in-house, STING (D2P2F) Rabbit Monoclonal Antibody (CST #13647) is ready to ship.
STING signaling remodels the tumor microenvironment by
2019年2月28日 · Mechanistic analyses reveal that STING represses NPC-derived MDSC induction by enhancing SOCS1 expression in both tumor cells and MDSCs. SOCS1 physically interacts with STAT3 through its SH2...
ARIH1 activates STING-mediated T-cell activation and ... - Nature
2023年7月10日 · Using an ICB-insensitive tumor model, here we discover cisplatin enhances the anti-tumor effect of PD-L1 blockade and upregulates the expression of Ariadne RBR E3 ubiquitin-protein ligase 1 (ARIH1)...
【研究专题】免疫信号通路cGAS-STING - 知乎 - 知乎专栏
cgas-sting通路是细胞内重要的免疫信号通路,负责识别病毒和细菌的双链dna(dsdna)。 cGAS结合dsDNA后生成环状GMP-AMP(cGAMP),激活STING(刺激性基因)。 活化的STING进一步招募TBK1并激活IRF3,促进I型干扰素和…
《自然》子刊:刷新认知!武大张军杰团队首次发现,STING竟是 …
2023年7月14日 · 小鼠肿瘤组织的免疫组化(IHC)染色表明, STING的表达抑制了肿瘤细胞的增殖,促进了肿瘤细胞的凋亡。 此外, STING在MC38细胞中的表达明显增加了淋巴细胞浸润。 具体而言,在STING表达的肿瘤中,肿瘤浸润的CD8阳性T细胞的占比增加,而CD4阳性T细胞的占比 …
STING通路又登顶刊,看看21.3分的文章如何揭示STING的新功能
2023年11月3日 · STING是一种公认的先天免疫信号转接器,通过协调骨髓细胞的先天感知和适应性免疫监视,在增强抗肿瘤免疫中起着关键作用。 STING作为细胞内在肿瘤抑制因子,在多种人类恶性肿瘤中明显沉默。 STING如何发挥内在的抗肿瘤活性尚不清楚。 本文报道 STING限制有氧糖酵解独立于其先天免疫功能。 在机制上,STING以 己糖激酶II (HK2)为靶点,阻断其己糖激酶活性。 因此,STING抑制HK2从而抑制肿瘤有氧糖酵解,促进体内抗肿瘤免疫。 在人类结直肠癌 …
热点解读丨STING:未成药靶点中备受偏爱的顶流 (附热门靶点IHC …
2024年5月16日 · 干扰素基因刺激因子(STING)在负责监测细胞质中DNA出现的cGAS-STING-IFN信号通路中处于中心位置,在先天性免疫中发挥着重要的作用,近年来,从抗肿瘤疗法、抑制炎症和自身免疫反应、到延缓衰老、延缓多种神经退行性疾病、及疫苗开发,靶向STING信号通路的应用都表现出了一定潜力和良好前景,因而这一靶点受到业内格外关注。
STING activation promotes robust immune response and NK cell ... - PNAS
This study reveals therapeutic potential and deep remodeling of the TME by STING activation in GBM and warrants further examination of STING agonists alone or in combination with other immunotherapies such as cancer vaccines, chimeric antigen receptor T cells, NK therapies, and immune checkpoint blockade.
ARID1A suppresses R-loop-mediated STING-type I interferon …
2024年5月15日 · ARID1A deficiency or cBAF inhibition induced a cell-intrinsic type I interferon (IFN) gene expression program (ARID1A-IFN), triggered by STING-dependent cytosolic DNA sensing resulting from increased R-loops, cytosolic single-stranded DNA (ssDNA), and cytosolic RNA:DNA hybrids.